These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18160587)

  • 1. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation.
    Ozel Demiralp D; Aktas H; Akar N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):438-46. PubMed ID: 18160587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
    Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
    Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
    Berberoğlu M; Evliyaoğlu O; Adiyaman P; Ocal G; Ulukol B; Simşek F; Siklar Z; Törel A; Ozel D; Akar N
    J Pediatr Endocrinol Metab; 2006 May; 19(5):741-8. PubMed ID: 16789641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
    Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.
    Zirlik A; Leugers A; Lohrmann J; Ernst S; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2004 Apr; 91(4):674-82. PubMed ID: 15045127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene.
    Nordt TK; Eschenfelder E; Peter K; Sobel BE; Bode C
    Thromb Haemost; 2003 Jul; 90(1):36-42. PubMed ID: 12876623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes.
    Gottschling-Zeller H; Röhrig K; Hauner H
    Diabetologia; 2000 Mar; 43(3):377-83. PubMed ID: 10768100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
    Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
    Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
    McCormack LJ; Nagi DK; Stickland MH; Mansfield MW; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
    Diabetologia; 1996 Dec; 39(12):1512-8. PubMed ID: 8960834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z; Jhun B; Jung SY; Oh CK
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
    Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.
    Solá E; Vayá A; España F; Castelló R; Ramón LA; Hernández-Mijares A; Vicente V; Estellés A
    Thromb Res; 2008; 122(3):320-7. PubMed ID: 18037477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.